Litigation Details for Genzyme Corp. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Genzyme Corp. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-11-13 |
| Court | District Court, D. Delaware | Date Terminated | 2020-08-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Parties | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | ||
| Patents | 6,916,802; 7,196,205; 7,253,185; 7,615,573 | ||
| Attorneys | Katherine E. Adams | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genzyme Corp. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Genzyme Corp. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-11-13 | 1 | of U.S. Patent No. 6,916,802 (the “’802 patent”), U.S. Patent No. 7,196,205 (the “’205 patent”), U.S.…U.S. Patent No. 7,253,185 (the “’185 patent”), and U.S. Patent No. 7,615,573 (the “’573 patent”) under … of the ’802 patent, claims 1 and 3-9 of the ’205 patent, claims 1-4 of the ’185 patent, and claims 1… of the ’802 patent, claims 1 and 3-9 of the ’205 patent, claims 1-4 of the ’185 patent, and claims 1… THE PATENTS-IN-SUIT 16. On July 12, 2005, the ’802 patent, titled “Amino | External link to document | |
| 2018-11-13 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,196,205 B2 ;6,916,802 B2 ;7,253,185…2018 3 August 2020 1:18-cv-01796 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
